foravirumab (99)							

Structure	

Heavy chain / Chaone lourde / Cadena pesada

EVQLVESGGG	AVQPGRSLRL	SCAASGFTFS	SYGMHWVRQA	PGKGLEWVAV	50

ILYDGSDKFY	ADSVKGRFTI	SRDNSKNTLY	LQMNSLRAED	TAVYYCAKVA	100

VAGTHFDYWG	QGTLVTVSSA	STKGPSVFPL	APSSKSTSGG	TAALGCLVKD	150

YFPEPVTVSW	NSGALTSGVH	TFPAVLQSSG	LYSLSSVVTV	PSSSLGTQTY	200

ICNVNHKPSN	TKVDKRVEPK	SCDKTHTCPP	CPAPELLGGP	SVFLFPPKPK	250

DTLMISRTPE	VTCVVVDVSH	EDPEVKFNWY	VDGVEVHNAK	TKPREEQYNS	300

TYRVVSVLTV	LHQDWLNGKE	YKCKVSNKAL	PAPIEKTISK	AKGQPREPQV	350

YTLPPSREEM	TKNQVSLTCL	VKGFYPSDIA	VEWESNGQPE	NNYKTTPPVL	400

DSDGSFFLYS	KLTVDKSRWQ	QGNVFSCSVM	HEALHNHYTQ	KSLSLSPG	448

Light chain / Chaone lygire / Cadena ligera

DIQMTQSPSS	LSASVGDRVT	ITCRASQGIR	NDLGWYQQKP	GKAPKLLIYA	50?

ASSLQSGVPS	RFSGSGSGTD	FTLTISSLQP	EDFATYYCQQ	LNSYPPTFGG	100?

GTKVEIKRTV	AAPSVFIFPP	SDEQLKSGTA	SVVCLLNNFY	PREAKVQWKV	150?

DNALQSGNSQ	ESVTEQDSKD	STYSLSSTLT	LSKADYEKHK	VYACEVTHQG	200?

LSSPVTKSFN	RGEC



214?

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

22-96	22??-96??	23?-88?	23???-88???	134?-194?	134???-194???	146-202
146??-202??

214?-222	214???-222??	228-228??	231-231??	263-323	263??-323??	369-427
369??-427??

Modified residues / Rysidus modifiys / Residuos modificados

E

1-1??

 	pyroglutamic acid

acide pyroglutamique

acido piroglutamico

Glycosylation sites / Sites de glycosylation / Posiciones de
glicosilaciun

Asn-299	Asn-299??



Molecular formula	C6400H9908N1716O1998S44

Description

immunoglobulin G1, anti-[rabies virus glycoprotein], Homo sapiens
monoclonal antibody, CR4098; gamma1 heavy chain (1-448) [Homo sapiens VH
(IGHV3-33-(IGHD)-IGHJ4*01) [8.8.12] (1-119) -IGHG1*03, CH3 K130>del
(120-448)], (222-214?)-disulfide with kappa light chain (1?-214?) [Homo
sapiens V-KAPPA (IGKV1-17-IGKJ4*01) [6.3.9] (1?-107?) -IGKC*01
(108?-214?)]; (228-228??:231-231??)-bisdisulfide dimer 

	

WHO 

International Nonproprietary Names Programme	

9053

1/1

		

